emtricitabine

FDA Drug Profile — emtricitabine

emtricitabine is listed in the FDA National Drug Code directory with 4 NDC codes, marketed under brand name including emtricitabine. Available dosage forms: capsule, powder.

Drug details

Generic Name
emtricitabine
Brand Names
emtricitabine
Application Number
ANDA091168
Sponsor
Cipla USA Inc.
NDC Codes
4
Dosage Forms
CAPSULE, POWDER
Routes
ORAL
Active Ingredients
EMTRICITABINE

Indications and Usage

1 INDICATIONS AND USAGE Emtricitabine is indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection. Emtricitabine, a nucleoside analog HIV-1 reverse transcriptase inhibitor, is indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection. ( 1 )

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.